title: Hybrid biosynthetic gene therapy vector development and dual engineering capacity.
abstract: Genetic vaccines offer a treatment opportunity based upon successful gene delivery to specific immune cell modulators. Driving the process is the vector chosen for gene cargo packaging and subsequent delivery to antigen-presenting cells (APCs) capable of triggering an immune cascade. As such, the delivery process must successfully navigate a series of requirements and obstacles associated with the chosen vector and target cell. In this work, we present the development and assessment of a hybrid gene delivery vector containing biological and biomaterial components. Each component was chosen to design and engineer gene delivery separately in a complimentary and fundamentally distinct fashion. A bacterial (Escherichia coli) inner core and a biomaterial [poly(beta-amino ester)]-coated outer surface allowed the simultaneous application of molecular biology and polymer chemistry to address barriers associated with APC gene delivery, which include cellular uptake and internalization, phagosomal escape, and intracellular cargo concentration. The approach combined and synergized normally disparate vector properties and tools, resulting in increased in vitro gene delivery beyond individual vector components or commercially available transfection agents. Furthermore, the hybrid device demonstrated a strong, efficient, and safe in vivo humoral immune response compared with traditional forms of antigen delivery. In summary, the flexibility, diversity, and potential of the hybrid design were developed and featured in this work as a platform for multivariate engineering at the vector and cellular scales for new applications in gene delivery immunotherapy.
authors.affiliation: Departments of Chemical and Biological Engineering and.
authors.forename: Charles H
authors.initials: CH
authors.lastname: Jones
authors.affiliation: Departments of Chemical and Biological Engineering and.
authors.forename: Anitha
authors.initials: A
authors.lastname: Ravikrishnan
authors.affiliation: Departments of Chemical and Biological Engineering and.
authors.forename: Mingfu
authors.initials: M
authors.lastname: Chen
authors.affiliation: Microbiology and Immunology, and.
authors.forename: Ryan
authors.initials: R
authors.lastname: Reddinger
authors.affiliation: Departments of Chemical and Biological Engineering and.
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Kamal Ahmadi
authors.affiliation: Departments of Chemical and Biological Engineering and.
authors.forename: Snehal
authors.initials: S
authors.lastname: Rane
authors.affiliation: Microbiology and Immunology, and The Witebsky Center for Microbial Pathogenesis and Immunology, University at Buffalo, The State University of New York, Buffalo, NY 14260-4200.
authors.forename: Anders P
authors.initials: AP
authors.lastname: Hakansson
authors.affiliation: Departments of Chemical and Biological Engineering and blainepf@buffalo.edu.
authors.forename: Blaine A
authors.initials: BA
authors.lastname: Pfeifer
mesh_terms: D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D002460:Cell Line; D004926:Escherichia coli / Q000235:genetics; D005260:Female; D018014:Gene Transfer Techniques / Q000639:trends; D005818:Genetic Engineering / Q000639:trends*; D015316:Genetic Therapy / Q000639:trends*; D005822:Genetic Vectors; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D023421:Models, Animal; D010047:Ovalbumin / Q000276:immunology; D019444:Vaccines, DNA / Q000235:genetics
chemical_list: D019444:Vaccines, DNA; D010047:Ovalbumin
keywords: bactofection; cationic polymers; immunization; nonviral vectors; vaccination
references.citation: J Mol Biol. 1986 May 5;189(1):113-30
references.pmid: 3537305
references.citation: Biomaterials. 2012 May;33(13):3594-603
references.pmid: 22341939
references.citation: J Immunol. 2007 May 15;178(10):6259-67
references.pmid: 17475854
references.citation: Nat Rev Drug Discov. 2005 Jul;4(7):581-93
references.pmid: 16052241
references.citation: Bioeng Bugs. 2012 Mar-Apr;3(2):86-92
references.pmid: 22095052
references.citation: Biomacromolecules. 2011 Oct 10;12(10):3592-600
references.pmid: 21888340
references.citation: PLoS One. 2010 Jan 13;5(1):e8668
references.pmid: 20084270
references.citation: Mol Microbiol. 1999 Mar;31(6):1631-41
references.pmid: 10209738
references.citation: Nature. 2013 Aug 15;500(7462):280-2
references.pmid: 23955226
references.citation: Gene Ther. 2004 Aug;11(15):1224-33
references.pmid: 15141160
references.citation: Mol Ther. 2007 Jul;15(7):1306-1312
references.pmid: 28182918
references.citation: Gene Ther. 2008 Mar;15(6):434-42
references.pmid: 18317498
references.citation: Arch Microbiol. 1992;157(4):381-8
references.pmid: 1534215
references.citation: Mol Pharm. 2013 Nov 4;10(11):4082-98
references.pmid: 24093932
references.citation: J Appl Microbiol. 2000 Dec;89(6):1048-58
references.pmid: 11123478
references.citation: Mol Ther. 2005 Mar;11(3):426-34
references.pmid: 15727939
references.citation: Mol Pharm. 2013 Nov 4;10(11):4301-8
references.pmid: 24093973
references.citation: Gene Ther. 2005 Nov;12(21):1559-72
references.pmid: 15973438
references.citation: Pharm Res. 2008 Aug;25(8):1815-21
references.pmid: 18373181
references.citation: Curr Opin Mol Ther. 2005 Apr;7(2):157-63
references.pmid: 15844624
references.citation: Methods Mol Biol. 2009;480:53-63
references.pmid: 19085119
references.citation: Gene Ther. 2002 Nov;9(21):1455-63
references.pmid: 12378408
references.citation: Gene Ther. 2005 Jul;12(13):1070-8
references.pmid: 15815705
references.citation: Acc Chem Res. 2008 Jun;41(6):749-59
references.pmid: 18507402
references.citation: Nat Biotechnol. 2013 Nov;31(11):957-60
references.pmid: 24213761
references.citation: Vaccine. 1999 Mar 26;17(13-14):1643-9
references.pmid: 10194817
references.citation: Mol Pharm. 2007 Jan-Feb;4(1):4-17
references.pmid: 17233543
references.citation: PLoS One. 2012;7(5):e37543
references.pmid: 22629417
references.citation: Gene. 1977;2(2):95-113
references.pmid: 344137
references.citation: Mol Ther. 2009 Jan;17(1):65-72
references.pmid: 19002167
references.citation: Cell Microbiol. 2002 Mar;4(3):177-86
references.pmid: 11906454
references.citation: PLoS One. 2010 Apr 06;5(4):e10051
references.pmid: 20386614
references.citation: Mol Pharm. 2012 Nov 5;9(11):3375-83
references.pmid: 22970908
references.citation: Bioconjug Chem. 2007 Nov-Dec;18(6):1887-96
references.pmid: 17929884
references.citation: Nat Biotechnol. 2006 Jun;24(6):697-702
references.pmid: 16699500
references.citation: Pharm Res. 2008 May;25(5):1202-8
references.pmid: 18343983
references.citation: J Biotechnol. 2008 Oct 10;137(1-4):59-64
references.pmid: 18694790
references.citation: Angew Chem Int Ed Engl. 2003 Jul 14;42(27):3153-8
references.pmid: 12866105
references.citation: Gene. 2013 Aug 10;525(2):162-9
references.pmid: 23618815
references.citation: Clin Cancer Res. 2004 Mar 15;10(6):1920-7
references.pmid: 15041707